Swoop
MyHealthTeam | Patient Insights
Swoop
Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters
Objective To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy. Background Challenges swallowing oral medications among children have been shown to affect adherence to treatment. This survey is of critical importance for the practicing neurologist, as it addresses issues related to medication formulation availability […]
MyHealthTeam | Patient Insights
Swoop
Patient Reported Attitudes Towards Multiple Sclerosis Treatment
Background Obstacles exist for getting patients on disease modifying treatments (DMTs) to slow progression. Understanding patient concerns can enable neurologists to help patients overcome barriers. Objective Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.
Swoop
Five fast lessons from Reuters Pharma USA 2025
Here are five quick takeaways from Reuters Pharma USA 2025
Predictive Audiences | Case Studies
Swoop
A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
DTC Audiences | Case Studies
Swoop
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
DTC Audiences | Case Studies
Swoop
Activating Patients on Addressable TV Generates 1,500 New-to-Brand Starts for Type 2 Diabetes Drug
A pharmaceutical brand wanted to increase reach, doctor’s visits and drive prescription lift of its Type 2 diabetes drug nationally. Swoop built a privacy-safe segment of patients on the brand and its competitors. Targeted ads on linear addressable devices scaled across MVPDs, maximizing frequency to saturate the North American market.
HCP Marketing | Case Studies
Swoop
Activating HCPs via CTV Leads to 12:1 ROI for Neurological Movement Disorder
Facing low brand awareness and unable to reach healthcare professionals prescribing competitive treatments, a neurological therapy sought to convert hard-to-reach HCPs. Swoop utilized NPI-to-device matching to serve 60-second promotions to targeted HCP households via CTV.
HCP Marketing | Case Studies
Swoop
Increasing Lift 22% by Activating Audiences within Leading EHRs and Programmatic Next-Best-Action Engagement
A pain management brand wanted to increase brand awareness and drive script lift among hard-to-reach HCPs by targeting them in EHR platforms. Swoop enabled the brand to activate key HCPs at the point-of-care while they were immersed in the clinical workflow within leading EHRs. To increase exposure within an omnichannel ecosystem, next best action programmatic […]
Swoop Agents | Case Studies
Swoop
Eliminating Knowledge Gaps and Improving Marketing Strategies with First-Party Data
A leading women’s health brand sought to improve the customer experience with streamlined engagement while gaining a better understanding of needs. Swoop Agents implemented on brand.com provided prospective and on-therapy patients and HCPs an always-on, easy-to-use resource for medical information, while generating valuable 1st party data.
HCP Marketing | Case Studies
Swoop
Capturing 2X the Industry Standard Engagement at a Major Oncology Conference
A leading multiple myeloma therapy wanted to increase brand awareness and engagement among influential KOLs. Swoop used its proprietary data graph and gated geotargeting capabilities to reach HCPs with targeted media messaging on personal devices while attending a landmark oncology conference.